SAN ANTONIO, Feb. 4, 2026 – For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, independence and quality of life. Often viewed as an ...
Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
Adding transcranial direct current stimulation (tDCS) to constraint-induced movement therapy (CIMT) after stroke offered no additional benefit in improving upper extremity function, new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results